Jordan E Vellky

4PUBLICATIONS
36CO-AUTHORS
PharmacogenomicsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 19, 2025
GLP1 receptor agonism alters growth and therapeutic response in prostate cancer.

Soumen Bera, Lisa C Gutgesell, Brynne Darden

|Aug 12, 2025
SOX2 utilizes FOXA1 as a heteromeric transcriptional partner to drive proliferation in therapy-resistant prostate cancer.

John T Phoenix, Audris Budreika, Devin A Schmeck

|Feb 02, 2024
ERBB3 Overexpression is Enriched in Diverse Patient Populations with Castration-sensitive Prostate Cancer and is Associated with a Unique AR Activity Signature.

Jordan E Vellky, Brenna J Kirkpatrick, Lisa C Gutgesell

|Oct 27, 2020
RNA-binding protein DDX3 mediates posttranscriptional regulation of androgen receptor: A mechanism of castration resistance.

Jordan E Vellky, Sean T McSweeney, Emily A Ricke

Pageof 1